Assessment of Medication Adherence in Ccu Admitted Patients

NCT07504406 | Not Yet Recruiting

• 1 other identifier: bmq ami hf af
• Study Type: observational
• Target: 250
• Locations: 1 country
• Sites: 2

Brief Summary

This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.

Conditions

Heart Failure; Atrial Fibrillation (AF)

Keywords

Medication adherence; MAI; BMQ; Atrial fibrillation; Heart failure; CCU; brief medication questionnaire; medication appropriateness index

Outcome Measures

Primary Outcomes (2)

• Medication adherence (BMQ)

  Medication adherence will be assessed using the Brief Medication Questionnaire (BMQ), a validated tool that evaluates medication-taking behavior and barriers to adherence.

  During CCU admission after clinical stabilization (assessed up to 5 days)

• Medication appropriateness measured by Medication Appropriateness Index (MAI)

  Medication appropriateness will be assessed using the Medication Appropriateness Index (MAI). The MAI score ranges from 0 to 12, where lower scores indicate better medication adherence and higher scores indicate poorer adherence.

  During CCU admission after clinical stabilization (assessed up to 5 days)

Study Arms (1)

CCU HF and AF Patients

Adult patients aged 18 years or older diagnosed with atrial fibrillation or heart failure and discharged from the coronary care unit.

Other: No intervention (observational study)

Interventions

No intervention (observational study) OTHER

This is an observational study with no active intervention.

CCU HF and AF Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients aged 18 years or older diagnosed with atrial fibrillation or heart failure who are admitted to the coronary care unit. Participants will be clinically stable at the time of assessment and able to provide informed consent.

You may qualify if:

• Adult patients aged 18 years or older
• Diagnosed with atrial fibrillation or heart failure
• Admitted to the coronary care unit
• Clinically stable at the time of interview
• Able to provide informed consent

You may not qualify if:

• Significant cognitive impairment
• Communication difficulties preventing interview
• Diagnosed psychiatric disorder interfering with participation

Sponsors & Collaborators

• AlFayhaa General Hospital: lead

Study Sites (2)

Al-Nasiriyah Heart Center

Nasiriyah, Thi Qar, Iraq

Location

Al-Nasiriyah Teaching Hospital

Nasiriyah, Thi Qar, Iraq

Location

MeSH Terms

Conditions

Heart Failure; Atrial Fibrillation; Medication Adherence

Interventions

Observation

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases; Arrhythmias, Cardiac; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Central Study Contacts

Suror S Alsabbagh, Bachelor of Pharmacy

CONTACT

+9647817091467; srooralsabbagh@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 3, 2026
• First Posted: March 31, 2026
• Study Start: March 1, 2026
• Primary Completion (Estimated): August 1, 2026
• Study Completion (Estimated): August 1, 2026
• Last Updated: March 31, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

IR (2)